EMAIL: [email protected]
PHONE: 720.213.5810

Omar Sacirbey

Omar has been a professional journalist since 1998, covering everything from international business and Wall Street to politics and religion. His stories have appeared in Newsweek International, the New York Times, the Washington Post, USA Today and other major outlets. Omar graduated from the Columbia University Graduate School of Journalism in 1998, and prior to that he was a Bosnian diplomat. He is based in Boston.

Vape crisis forced cannabis sector to increase focus on technology, testing and transparency

Published February 23, 2020 | By Omar Sacirbey

A health emergency in which dozens of people died and 2,600-plus were admitted to hospitals immediately took its toll on vape-related companies, and all signs pointed to an additive, vitamin E acetate, which officials found in some of the implicated THC vaping products.

Cannabis execs anticipate expanded legal markets in 2020 – and ensuing challenges

Published January 31, 2020 | By Omar Sacirbey

Cannabis executives, professionals and financiers can expect 2020 – and the rest of the new decade – to have at least as much impact on their businesses as any year in the past 10.

The stories behind cannabis companies and their partnerships with mainstream businesses

Published December 28, 2019 | By Omar Sacirbey

An unthinkable collaboration not long ago, more and more marijuana businesses and mainstream companies are joining forces on products such as sleep-inducing CBD gummies, infused beverages and pharmaceutical-grade medications.

The future of the medical marijuana industry: Q&A with Andrea Small-Howard, chief science officer at GB Sciences

Published December 12, 2019 | By Omar Sacirbey

Andrea Small-Howard has a unique view into how the medical side of the cannabis space is evolving. She’s the chief science officer at GB Sciences, a Las Vegas-based marijuana company pursuing two strategies – one recreational, and the other aiming for U.S. Food and Drug Administration (FDA) approval of its medical cannabis products. Small-Howard has […]

Demise of medical cannabis markets might be much ado about nothing

Published October 29, 2019 | By Omar Sacirbey

Media reports abound that suggest medical marijuana markets have leveled out or are dropping off in some U.S. states – specifically those that allow recreational cannabis sales.

Global Cannabis: Seven Global Players Worth Watching

Published September 6, 2019 | By Omar Sacirbey

There are seven businesses worth watching as they attempt to capitalize on the numerous business opportunities in the global marijuana market for entrepreneurs and companies with ambition. And check mjbizdaily.com/intl often for new updates. Looking for where else the action is taking place in the global cannabis market? Here is our list of seven countries to keep […]

Global cannabis trends and game-changers: Q&A with Narbé Alexandrian, CEO of Canopy Rivers

Published September 4, 2019 | By Omar Sacirbey

Since taking the helm at Canopy Rivers, the investment affiliate of Canopy Growth, Narbé Alexandrian has seen the cannabis industry go from dipping its toes into global waters to plunging in headfirst.

Global Cannabis: Jamaica

Published September 4, 2019

Milestones in the Medical Cannabis Program In 2015, Jamaica amended its so-called Dangerous Drug Act, which prohibited and punished marijuana cultivation, distribution and consumption, to establish a Cannabis Licensing Authority and develop an MMJ industry. In 2016, authorities finalized regulations and began accepting business license applications. Key Laws and Regulations Dangerous Drugs Act of […]

Global Cannabis: Israel

Published September 4, 2019

Milestones in the Medical Cannabis Program Israel has allowed medical cannabis use with a physician’s prescription since 1973, but an industry didn’t begin to take shape until the 1990s. Key Laws and Regulations Dangerous Drugs Ordinance of 1973 Government Resolution 1587 of 2016 Dangerous Drugs Ordinance, Amendment 16 of 2019 Market Data Israel’s […]

Craft cannabis is the marijuana industry’s small-batch sector

Published August 31, 2019 | By Omar Sacirbey

The cannabis industry is becoming increasingly dominated by big firms, but there still is room for small, craft marijuana producers who peddle high-end products ranging from flower to edibles.

Craft cannabis, capitalism & for-profit co-ops: Q&A with Flow Kana CEO Michael Steinmetz

Published August 8, 2019 | By Omar Sacirbey

In a time when giant multistate marijuana companies dominate the U.S. cannabis landscape, legitimate concerns exist that they will drive craft and small cultivators out of the legal cannabis industry. But Michael Steinmetz, who founded California cannabis company Flow Kana in 2015, believes big-time capitalism – or at least his business model – can save […]

Philadelphia medical marijuana research center in flux

Published July 29, 2019

A Philadelphia research center that initially was expected to provide an economic boost to the medical cannabis industry is fighting for survival. The Lambert Center for the Study of Medical Cannabis and Hemp is struggling in the wake of losing key staff and allegations of mismanagement and sexual harassment, according to The Philadelphia Inquirer. A […]

Event News

Investor Intelligence

News Briefs

Follow Us

February Issue

Get Our Daily Email

Get our daily email